Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 216

1.

Glutamic acid decarboxylase autoantibodies in preclinical insulin-dependent diabetes.

De Aizpurua HJ, Wilson YM, Harrison LC.

Proc Natl Acad Sci U S A. 1992 Oct 15;89(20):9841-5.

3.
4.

A monoclonal antibody-based characterization of autoantibodies against glutamic acid decarboxylase in adults with latent autoimmune diabetes.

Ziegler B, Strebelow M, Rjasanowski I, Schlosser M, Ziegler M.

Autoimmunity. 1998;28(2):61-8.

PMID:
9771977
5.

Cytoplasmic islet cell antibodies recognize distinct islet antigens in IDDM but not in stiff man syndrome.

Richter W, Seissler J, Northemann W, Wolfahrt S, Meinck HM, Scherbaum WA.

Diabetes. 1993 Nov;42(11):1642-8.

PMID:
8405707
7.

Antibodies to islet 37k antigen, but not to glutamate decarboxylase, discriminate rapid progression to IDDM in endocrine autoimmunity.

Christie MR, Genovese S, Cassidy D, Bosi E, Brown TJ, Lai M, Bonifacio E, Bottazzo GF.

Diabetes. 1994 Oct;43(10):1254-9.

PMID:
7926297
9.

Brain-reactive autoantibodies in BB/d rats do not recognize glutamic acid decarboxylase.

Davenport C, Lovell H, James RF, Todd I.

Clin Exp Immunol. 1995 Jul;101(1):127-35.

10.

Autoantibodies to glutamic acid decarboxylase (GAD) detected by an immuno-trapping enzyme activity assay: relation to insulin-dependent diabetes mellitus and islet cell antibodies.

Martino GV, Tappaz ML, Braghi S, Dozio N, Canal N, Pozza G, Bottazzo GF, Grimaldi LM, Bosi E.

J Autoimmun. 1991 Dec;4(6):915-23.

PMID:
1812896
11.
12.

Persistent GAD 65 antibodies in longstanding IDDM are not associated with residual beta-cell function, neuropathy or HLA-DR status.

Jaeger C, Allendörfer J, Hatziagelaki E, Dyrberg T, Bergis KH, Federlin K, Bretzel RG.

Horm Metab Res. 1997 Oct;29(10):510-5.

PMID:
9405979
13.

An ELISA for antibodies to recombinant glutamic acid decarboxylase in IDDM.

DeAizpurua HJ, Harrison LC, Cram DS.

Diabetes. 1992 Sep;41(9):1182-7.

PMID:
1499869
15.

Prevalence of autoantibodies to the 65- and 67-kD isoforms of glutamate decarboxylase in insulin-dependent diabetes mellitus.

Seissler J, Amann J, Mauch L, Haubruck H, Wolfahrt S, Bieg S, Richter W, Holl R, Heinze E, Northemann W, et al.

J Clin Invest. 1993 Sep;92(3):1394-9.

16.

Detection of GAD65 antibodies in diabetes and other autoimmune diseases using a simple radioligand assay.

Petersen JS, Hejnaes KR, Moody A, Karlsen AE, Marshall MO, Høier-Madsen M, Boel E, Michelsen BK, Dyrberg T.

Diabetes. 1994 Mar;43(3):459-67.

PMID:
8314020
17.
18.

Antibodies to glutamic acid decarboxylase in Australian children with insulin-dependent diabetes mellitus and their first-degree relatives.

Chen QY, Rowley MJ, Byrne GC, Jones TW, Tuomi T, Knowles WJ, Zimmet PZ, Mackay IR.

Pediatr Res. 1993 Dec;34(6):785-90.

PMID:
8108194
19.

Combined analysis of islet cell antibodies that cross-react with mouse pancreas, antibodies to the M(r) 64,000 islet protein, and antibodies to glutamate decarboxylase in type I diabetic patients.

Chaillous L, Delamaire M, Martignat L, Maugendre D, Marre M, Mathieu E, Limal JM, Charbonnel B, Allannic H, Saï P.

Diabetes Care. 1994 Oct;17(10):1115-23.

PMID:
7821130
20.

Islet cell antibodies: variable immunostaining of pancreatic islet cells and carcinoid tissue.

Hallberg A, Juhlin C, Berne C, Kämpe O, Karlsson FA.

J Intern Med. 1995 Sep;238(3):207-13.

PMID:
7673849

Supplemental Content

Support Center